Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool

The current screening test for prostate cancer (PCa) has the weak point of a high false-negative rate and a low true positive rate. There is an extreme need for a new and accurate testing system. Circulating Tumor Cells (CTCs) as the main liquid biopsy components provide excellent biomarkers for ear...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fatemeh Khatami, Mandana Hasanzad
Formato:	article
Lenguaje:	EN
Publicado:	Urology Research Center 2020
Materias:	circulating tumor cells prostate cancer benign prostatic hyperplasia Diseases of the genitourinary system. Urology RC870-923
Acceso en línea:	https://doaj.org/article/e4a7a1e2bb81432fba647a281a2133e2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e4a7a1e2bb81432fba647a281a2133e2
record_format	dspace
spelling	oai:doaj.org-article:e4a7a1e2bb81432fba647a281a2133e22021-11-29T07:51:25ZCirculating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool10.22034/TRU.2020.260779.10552717-042Xhttps://doaj.org/article/e4a7a1e2bb81432fba647a281a2133e22020-08-01T00:00:00Zhttps://www.transresurology.com/article_120191.htmlhttps://doaj.org/toc/2717-042XThe current screening test for prostate cancer (PCa) has the weak point of a high false-negative rate and a low true positive rate. There is an extreme need for a new and accurate testing system. Circulating Tumor Cells (CTCs) as the main liquid biopsy components provide excellent biomarkers for early diagnosis of PCa, prognosis, recurrence risk, and treatment efficacy. These tumor cells can get the release of tumor and freely circulate in the patient’s body fluids and easily are traceable to answer the presence of the tumor more than its stage. The new gifted ISET®-CTC Test is a simple blood test with high sensitivity and specificity for the detection of CTC in PCa. As a novel idea, it is a challengeable point nowadays that it needs further studies. Fatemeh Khatami Mandana HasanzadUrology Research Centerarticlecirculating tumor cellsprostate cancerbenign prostatic hyperplasiaDiseases of the genitourinary system. UrologyRC870-923ENTranslational Research in Urology, Vol 2, Iss 3, Pp 93-95 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	circulating tumor cells prostate cancer benign prostatic hyperplasia Diseases of the genitourinary system. Urology RC870-923
spellingShingle	circulating tumor cells prostate cancer benign prostatic hyperplasia Diseases of the genitourinary system. Urology RC870-923 Fatemeh Khatami Mandana Hasanzad Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
description	The current screening test for prostate cancer (PCa) has the weak point of a high false-negative rate and a low true positive rate. There is an extreme need for a new and accurate testing system. Circulating Tumor Cells (CTCs) as the main liquid biopsy components provide excellent biomarkers for early diagnosis of PCa, prognosis, recurrence risk, and treatment efficacy. These tumor cells can get the release of tumor and freely circulate in the patient’s body fluids and easily are traceable to answer the presence of the tumor more than its stage. The new gifted ISET®-CTC Test is a simple blood test with high sensitivity and specificity for the detection of CTC in PCa. As a novel idea, it is a challengeable point nowadays that it needs further studies.
format	article
author	Fatemeh Khatami Mandana Hasanzad
author_facet	Fatemeh Khatami Mandana Hasanzad
author_sort	Fatemeh Khatami
title	Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
title_short	Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
title_full	Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
title_fullStr	Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
title_full_unstemmed	Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool
title_sort	circulating tumor cells as a novel prostate cancer diagnostic tool
publisher	Urology Research Center
publishDate	2020
url	https://doaj.org/article/e4a7a1e2bb81432fba647a281a2133e2
work_keys_str_mv	AT fatemehkhatami circulatingtumorcellsasanovelprostatecancerdiagnostictool AT mandanahasanzad circulatingtumorcellsasanovelprostatecancerdiagnostictool
_version_	1718407557544935424

Circulating Tumor Cells as a Novel Prostate Cancer Diagnostic Tool

Ejemplares similares